Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Medicine and Surgery

Anemia Management

Advances in Pediatric Intravenous Iron Therapy.

Mantadakis E.

Source‎: Pediatr Blood Cancer 2016;63(1):11-6.

Indexed‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

Association of postoperative furosemide use with a reduced blood transfusion rate in sagittal craniosynostosis surgery.

Harroud A, Weil AG, Turgeon J, Mercier C, Crevier L.

Source‎: J Neurosurg Pediatr 2015 Oct. [Epub ahead of print]

Indexed‎: PubMed 26431247

DOI‎: 10.3171/2015.5.PEDS14666

Clinical outcomes associated with RBC transfusions in critically ill children: a 1-year prospective study.

Demaret P, Tucci M, Karam O, Trottier H, Ducruet T, Lacroix J.

Source‎: Pediatr Crit Care Med 2015 Jul;16(6):505-14.

Indexed‎: PubMed 25905491

DOI‎: 10.1097/PCC.0000000000000423

Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose.

Shimpo H, Mizumoto T, Onoda K, Yuasa H, Yada I.

Source‎: Chest 1997;111(6):1565-70.

Indexed‎: PubMed 9187175

Management of severe anemia without transfusion in a pediatric Jehovah’s Witness patient.

Akingbola O, Custer J, Bunchman T, Sedman A.

Source‎: Crit Care Med 1994;22(3):524-7.

Indexed‎: PubMed 8125005

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.

Crary SE, Hall K, Buchanan GR.

Source‎: Pediatr Blood Cancer 2011;56(4):615-9.

Indexed‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.

Bierer R, Roohi M, Peceny C, Ohls RK.

Source‎: J Pediatr Surg 2009;44(8):1540-5.

Indexed‎: PubMed 19635302

DOI‎: 10.1016/j.jpedsurg.2008.10.112

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Source‎: Pediatr Blood Cancer 2009;53(1):7-12.

Indexed‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

Extensive lower limb injuries in a child complicated by complex pain management and profound anemia.

Rizzo G, Astuto M, Withington DE.

Source‎: Paediatr Anaesth 2008;18(8):779-81.

Indexed‎: PubMed 18482236

DOI‎: 10.1111/j.1460-9592.2008.02598.x

The care of a child with multiple trauma and severe anemia who was a Jehovah's Witness.

Digieri LA, Pistelli IP, de Carvalho CE.

Source‎: Hematology 2006;11(3):187-91.

Indexed‎: PubMed 17325960

Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?

Liet JM, Paranon S, Baraton L, Dejode JM, Roze JC.

Source‎: Pediatr Crit Care Med 2006;7(6):541-4.

Indexed‎: PubMed 17006380

Use of erythropoietin for bloodless surgery in a Jehovah's Witness infant.

Pérez-Ferrer A, De Vicente J, Gredilla E, García-Vega MI, Bourgeois P, Goldman LJ.

Source‎: Paediatr Anaesth 2003;13(7):633-6.

Indexed‎: PubMed 12950867

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.